164 related articles for article (PubMed ID: 15247211)
1. Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function.
Gergs U; Boknik P; Buchwalow I; Fabritz L; Matus M; Justus I; Hanske G; Schmitz W; Neumann J
J Biol Chem; 2004 Sep; 279(39):40827-34. PubMed ID: 15247211
[TBL] [Abstract][Full Text] [Related]
2. The cardiac-specific nuclear delta(B) isoform of Ca2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity.
Zhang T; Johnson EN; Gu Y; Morissette MR; Sah VP; Gigena MS; Belke DD; Dillmann WH; Rogers TB; Schulman H; Ross J; Brown JH
J Biol Chem; 2002 Jan; 277(2):1261-7. PubMed ID: 11694533
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.
Kirchhefer U; Baba HA; Bokník P; Breeden KM; Mavila N; Brüchert N; Justus I; Matus M; Schmitz W; Depaoli-Roach AA; Neumann J
Cardiovasc Res; 2005 Oct; 68(1):98-108. PubMed ID: 15975567
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β.
Hoehn M; Zhang Y; Xu J; Gergs U; Boknik P; Werdan K; Neumann J; Ebelt H
Int J Cardiol; 2015 Mar; 183():39-46. PubMed ID: 25662052
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice.
Dörner MF; Boknik P; Köpp F; Buchwalow IB; Neumann J; Gergs U
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502355
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cardiac contractility by serine/threonine protein phosphatase type 5.
Gergs U; Boknik P; Buchwalow IB; Fabritz L; Gründker N; Kucerova D; Matus M; Werner F; Schmitz W; Neumann J
Int J Cardiol; 2012 Jan; 154(2):116-21. PubMed ID: 20875921
[TBL] [Abstract][Full Text] [Related]
7. Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart.
Lüss H; Klein-Wiele O; Bokník P; Herzig S; Knapp J; Linck B; Müller FU; Scheld HH; Schmid C; Schmitz W; Neumann J
J Mol Cell Cardiol; 2000 Dec; 32(12):2349-59. PubMed ID: 11113010
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart.
Matsui T; Li L; Wu JC; Cook SA; Nagoshi T; Picard MH; Liao R; Rosenzweig A
J Biol Chem; 2002 Jun; 277(25):22896-901. PubMed ID: 11943770
[TBL] [Abstract][Full Text] [Related]
9. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
10. Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivo.
Puhl SL; Weeks KL; Güran A; Ranieri A; Boknik P; Kirchhefer U; Müller FU; Avkiran M
Cardiovasc Res; 2019 Mar; 115(3):519-529. PubMed ID: 30203051
[TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy.
Eleftheriadou O; Boguslavskyi A; Longman MR; Cowan J; Francois A; Heads RJ; Wadzinski BE; Ryan A; Shattock MJ; Snabaitis AK
Basic Res Cardiol; 2017 Jul; 112(4):37. PubMed ID: 28526910
[TBL] [Abstract][Full Text] [Related]
13. Function and regulation of serine/threonine phosphatases in the healthy and diseased heart.
Heijman J; Dewenter M; El-Armouche A; Dobrev D
J Mol Cell Cardiol; 2013 Nov; 64():90-8. PubMed ID: 24051368
[TBL] [Abstract][Full Text] [Related]
14. The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function.
Gresham KS; Stelzer JE
J Physiol; 2016 Feb; 594(3):669-86. PubMed ID: 26635197
[TBL] [Abstract][Full Text] [Related]
15. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein.
Kloeker S; Reed R; McConnell JL; Chang D; Tran K; Westphal RS; Law BK; Colbran RJ; Kamoun M; Campbell KS; Wadzinski BE
Protein Expr Purif; 2003 Sep; 31(1):19-33. PubMed ID: 12963337
[TBL] [Abstract][Full Text] [Related]
16. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium.
Münch G; Bölck B; Karczewski P; Schwinger RH
J Mol Cell Cardiol; 2002 Mar; 34(3):321-34. PubMed ID: 11945024
[TBL] [Abstract][Full Text] [Related]
17. Regulation of sarcoplasmic reticulum Ca
Terentyev D; Hamilton S
J Mol Cell Cardiol; 2016 Dec; 101():156-164. PubMed ID: 27585747
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational regulation of Drosophila PERIOD protein by protein phosphatase 2A.
Sathyanarayanan S; Zheng X; Xiao R; Sehgal A
Cell; 2004 Feb; 116(4):603-15. PubMed ID: 14980226
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 2A catalytic subunit α (PP2Acα) maintains survival of committed erythroid cells in fetal liver erythropoiesis through the STAT5 pathway.
Chen W; Gu P; Jiang X; Ruan HB; Li C; Gao X
Am J Pathol; 2011 May; 178(5):2333-43. PubMed ID: 21514445
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium.
Gupta RC; Neumann J; Watanabe AM; Sabbah HN
Biochem Pharmacol; 2002 Mar; 63(6):1069-76. PubMed ID: 11931839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
